Sodium Hyaluronate 32 mg/mL

sodium hyaluronate · IBSA Farmaceutici Italia Srl

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sodium Hyaluronate 32 mg/mL, covering 2025-04-06 to 2025-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness [NA]